Fangda Partners represent major global and PRC sponsors in their Chinese private equity investments, handling all kinds of complex transactions that span private and cross-border buyouts, equity and debt investments, portfolio secondaries and co-investments. Chen Bao leads the practice from Beijing, with his practice focusing on multijurisdictional M&A, and PE and venture capital financings. Yingjie Wang is also a key contact in Beijing, servicing a wide range of market participants from financial sponsors and venture capitalists to banks and alternative financing providers. In Shanghai, Helen Fan has extensive experience in the TMT, healthcare, consumer and renewable energy sectors, while Patrick Li is a respected authority on foreign direct investment.
Testimonials
Collated independently by Legal 500 research team.
‘Fangda's legal team is good at handling complex venture capital projects and providing clients with appropriate and professional services. Compared with other law firms, the professionalism is higher and the service quality is higher.’
‘Have a deep understanding of the industry, serve buyers and sellers, and understand the demands of all parties, so as to accurately grasp customer needs and solve problems in transactions in multiple ways.’
‘Rich experience in legal services in the field of equity investment.’
‘Quick responses and down-to-earth.’
‘Private equity and venture capital business is very good, with high professional level, good English, business thinking and customer awareness; one of the top internal firms in China.’
Key clients
- Chengxin Technology
- China Integrated Circuit Industry Fund II
- IDG
- Alibaba
- ABI
- XYZ Robotics Global Inc.
- Sunshine Insurance and a Sovereign Wealth Fund
- New Carzone
- China Life Insurance and Ping An Life Insurance
- FountainVest Partners
- MediTrust Health
- 360 Security Technology Inc.
- Peak
- Yunfeng Capital
- Hillhouse Capital
- CD Finance
- Shuangbai Fund
- InnoScience (Suzhou) Technology Co., Ltd.
- Nio Capital
- Suzhou Industrial Park Investment Fund L.P.
- CDBC
- CICC (Keyuan Dongxin and Shangqi Xinxing)
- China Mobile Capital Holding Co., Ltd.
- China State-owned Enterprise Mixed Ownership Reform Fund Co., Ltd.
- Quan Capital
- Gaolin Capital
- Shanghai Advanced Silicon Technology Co., Ltd.
- National Manufacturing Transformation and Upgrading Fund (国家制造业转型升级基金), National Green Development Fund (国家绿色发展基金), Comprehensive Reform Fund (综改基金) and Zhejiang Industrial Fund (浙江省产业基金)
- Dongfang Jingyuan Electron Limited
- DiaSys Diagnostic System GmbH
- CICC Zhongdian and CICC Zhixing
- Taikang Life
- Nanjing Xiezhong Auto-Airconditioner (Group) Co., Ltd.
- CPE
- Hasten Biopharma
- Marching-Power Technology
- Sequoia China
Work highlights
- Acted for Nio Capital on its Series Pre-A investment in Sunwoda Electric Vehicle Battery Co., Ltd.
- Advised two funds managed by CICC (Keyuan Dongxin and Shangqi Xinxing) in the setting up of their SPV (“CICC funds’ SPV”) and the equity investment in Huada SEMICONDUCTOR Co., Ltd.
Lawyers
Practice head
The lawyer(s) leading their teams.
Chen Bao